N-methyl-2-pyridone-5-carboxamide

1. Nicotinamide mononucleotide increases N-methyl-2-pyridone-5-carboxamide in humans.

   “Plasma concentrations of N-methyl-2-pyridone-5-carboxamide and N-methyl-4-pyridone-5-carboxamide were significantly increased dose-dependently by NMN administration.”

   Human trialoralplasma100, 250, and 500 mg5 hmalesn = 10

   Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men

   Endocrine journal·2 Nov 2019

More on Nicotinamide mononucleotide